Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GE.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.99ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.99ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.99ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.99NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
HW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FE.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FE.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GM.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GM.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GM.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FT.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FT.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used